Literature DB >> 11251673

Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with Type 2 diabetes mellitus.

S Mehrotra1, K L Ling, Y Bekele, E Gerbino, K A Earle.   

Abstract

AIMS: The reasons for the increased incidence of diabetic nephropathy in African-Caribbean compared with Caucasian subjects are poorly understood. Increased oxidative stress is linked to the development of endothelial dysfunction and histological abnormalities associated with diabetic renal disease. Therefore, it was assessed whether a marker of oxidative stress, lipid hydroperoxide (LOOH) and endothelial damage, von Willebrand factor (vWF) varied according to ethnic origin in the presence or absence of early diabetic nephropathy.
METHODS: Eighty-eight patients with Type 2 diabetes mellitus of African-Caribbean or Caucasian origin without a history of cardiovascular disease or clinical proteinuria were studied. Patients were classified as having microalbuminuria or normal albumin excretion. Fasting plasma vWF and LOOH were measured by an inhouse enzyme-linked immunoassay and ferrous oxidation with xylenol orange (FOX) assay, respectively. The relationship of LOOH to urinary albumin status, the metabolic disturbances of diabetes, blood pressure and ethnic origin were assessed using multivariate analysis.
RESULTS: Compared with Caucasian patients those of African-Caribbean origin had higher systolic blood pressure and HDL-cholesterol (157.8 +/- 17.0 vs. 147.8 +/- 24.4, P = 0.041 and 1.6 +/- 0.4 vs. 1.3 +/- 0.5, P = 0.018) but lower total triglycerides (1.3 +/- 0.8 vs. 1.9 +/- 1.1, P = 0.008). LOOH was significantly higher in the African-Caribbean patients compared with Caucasians (5.98 +/- 2.49 vs. 4.49 +/- 2.19, P = 0.006). vWF tended to be higher in microalbuminuric patients but showed no variation with ethnicity. In logistic regression analysis, LOOH was the only independent predictor of a raised albumin excretion rate (P = 0.008). In multiple regression analysis, African-Caribbean ethnicity (P = 0.020) HDL-cholesterol (P = 0.036), total triglycerides (P = 0.002) and a raised albumin excretion rate (P = 0.002) were independent predictors of LOOH.
CONCLUSIONS: In this group of Type 2 diabetic patients an increase in LOOH is associated with abnormal urinary albumin excretion. African-Caribbean origin was a determinant of LOOH independently of microalbuminuria. It is postulated that increased oxidative stress is of pathophysiological significance in accelerating the development of renal disease in African-Caribbean patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251673     DOI: 10.1046/j.1464-5491.2001.00416.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

1.  Differences in systemic oxidative stress based on race and the metabolic syndrome: the Morehouse and Emory Team up to Eliminate Health Disparities (META-Health) study.

Authors:  Alanna A Morris; Liping Zhao; Riyaz S Patel; Dean P Jones; Yusuf Ahmed; Neli Stoyanova; Gary H Gibbons; Viola Vaccarino; Rebecca Din-Dzietham; Arshed A Quyyumi
Journal:  Metab Syndr Relat Disord       Date:  2012-03-02       Impact factor: 1.894

Review 2.  Oxidative stress in diabetic nephropathy: basic and clinical information.

Authors:  H Ha; H B Lee
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

3.  Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of gamma-glutamylcysteine ligase.

Authors:  Sailendra N Nichenametla; Irina Ellison; Ana Calcagnotto; Philip Lazarus; Josh E Muscat; John P Richie
Journal:  Free Radic Biol Med       Date:  2008-05-24       Impact factor: 7.376

4.  Lifestyle advice follow-up improve glycemic control, redox and inflammatory status in patients with type 2 diabetes.

Authors:  Nadia Mahdad; Farida Ouda Boukortt; Zakaria Benzian; Malika Bouchenak
Journal:  J Diabetes Metab Disord       Date:  2014-12-17

5.  Race/ethnicity determines the relationships between oxidative stress markers and blood pressure in individuals with high cardiovascular disease risk.

Authors:  G Kapuku; F Treiber; F Raouane; J Halbert; H Davis; S Young-Mayes; V Robinson; G Harshfield
Journal:  J Hum Hypertens       Date:  2016-06-16       Impact factor: 3.012

6.  The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy.

Authors:  Xing-Guang Zhang; Yan-Qi Zhang; Qian-Peng Cheng; Yi Cao; Jian-Min Sun; Xiao-Feng Lv
Journal:  Eur J Med Res       Date:  2018-02-12       Impact factor: 2.175

7.  Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy.

Authors:  Giovanni Conti; Daniela Caccamo; Rossella Siligato; Guido Gembillo; Ersilia Satta; Dario Pazzano; Nicolina Carucci; Antonio Carella; Giuliana Del Campo; Antonino Salvo; Domenico Santoro
Journal:  Medicina (Kaunas)       Date:  2019-10-07       Impact factor: 2.430

Review 8.  Contribution of Adipose Tissue Oxidative Stress to Obesity-Associated Diabetes Risk and Ethnic Differences: Focus on Women of African Ancestry.

Authors:  Pamela A Nono Nankam; Télesphore B Nguelefack; Julia H Goedecke; Matthias Blüher
Journal:  Antioxidants (Basel)       Date:  2021-04-19

9.  An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes.

Authors:  Jeffrey W Stephens; Steven J Hurel; Jayshree Acharya; Steve E Humphries
Journal:  Cardiovasc Diabetol       Date:  2004-03-01       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.